{
    "organizations": [],
    "uuid": "c1f486181734187f3b7e55a2005d383a413390f0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/markets-swiss-stocks/swiss-stocks-factors-to-watch-on-feb-8-idUSL8N1PX766",
    "ord_in_thread": 0,
    "title": "Swiss stocks - Factors to watch on Feb 8",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "ZURICH, Feb 8 (Reuters) - The Swiss blue-chip SMI was seen opening 0.3 percent lower at 8,949 points on Thursday, according to premarket indications by bank Julius Baer .\nHere are some of the main factors that may affect Swiss stocks:\nSWISS RE Swiss Re is in preliminary discussions with Japan’s SoftBank Group on a potential minority investment in the Swiss reinsurer, the Zurich-based group said on Wednesday. The statement followed a report in the Wall Street Journal that the two groups were in advanced talks on a deal that could be worth $10 billion or more.\nFOR MORE CLICK ON ABB ABB gave a brighter outlook for 2018, saying it saw improving markets around the world after its overhaul hit the engineering group’s fourth-quarter earnings.\nFor more news see\nZURICH INSURANCE Zurich Insurance reported better-than-expected earnings as the insurer dealt with a raft of natural catastrophe losses and a sluggish investment environment.\nCREDIT SUISSE Switzerland’s Financial Market Supervisory Authority on Wednesday said it was in contact with Credit Suisse CSGN.S regarding a product betting on future swings in the S&P 500, which Credit Suisse on Tuesday said it would terminate after its value plunged.\nCOMPANY STATEMENTS * Roche Holding AG purchases shares in tender offer for Ignyta Inc.\n* Novartis AG says gets FDA approval for Cosentyx label update to include moderate-to-severe scalp psoriasis\n* Zur Rose Group AG says on draft coalition agreement in Germany: RX mail-order ban not to be justified; in interest of patients will therefore take all necessary legal and operative steps both in Germany and at European level\n* Molecular Partners AG operating loss of chf 25.8 million and net loss of chf 25.4 million in 2017\n* Basellandschaftliche Kantonalbank FY profit of 133.3 million francs at the same level as in the previous year\n* Leonteq AG net profit improved by 34% to chf 23.1 million in 2017‍​\n* Leclanche SA says building complete energy storage systems for commercial and industrial applications with nrstor c&i in Canada\n* Bank Cler AG annual profit chf 38.3 million (2016: chf 45.7 million)\n* Emmi AG ‍group sales of chf 3,364.3 million in 2017, an increase of 3.2 %\n* Glarner Kantonalbank operating income increases by 8% to 70 million francs; net income increases by 14.1 per cent to 20.0 million francs\n* Vifor Pharma AG: Ferroportin inhibitor enters phase-I clinical trial\n* Lem Holding SA: 9mth bookings amounted to chf 235.5 million, an increase of 17.7% (chf 200.0 million) ‍​‍​\nECONOMY Reporting by Zurich newsroom\n ",
    "published": "2018-02-08T13:36:00.000+02:00",
    "crawled": "2018-02-09T16:59:04.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "zurich",
        "feb",
        "reuters",
        "swiss",
        "smi",
        "seen",
        "opening",
        "percent",
        "lower",
        "point",
        "thursday",
        "according",
        "premarket",
        "indication",
        "bank",
        "julius",
        "baer",
        "main",
        "factor",
        "may",
        "affect",
        "swiss",
        "stock",
        "swiss",
        "swiss",
        "preliminary",
        "discussion",
        "japan",
        "softbank",
        "group",
        "potential",
        "minority",
        "investment",
        "swiss",
        "reinsurer",
        "group",
        "said",
        "wednesday",
        "statement",
        "followed",
        "report",
        "wall",
        "street",
        "journal",
        "two",
        "group",
        "advanced",
        "talk",
        "deal",
        "could",
        "worth",
        "billion",
        "click",
        "abb",
        "abb",
        "gave",
        "brighter",
        "outlook",
        "saying",
        "saw",
        "improving",
        "market",
        "around",
        "world",
        "overhaul",
        "hit",
        "engineering",
        "group",
        "earnings",
        "news",
        "see",
        "zurich",
        "insurance",
        "zurich",
        "insurance",
        "reported",
        "earnings",
        "insurer",
        "dealt",
        "raft",
        "natural",
        "catastrophe",
        "loss",
        "sluggish",
        "investment",
        "environment",
        "credit",
        "suisse",
        "switzerland",
        "financial",
        "market",
        "supervisory",
        "authority",
        "wednesday",
        "said",
        "contact",
        "credit",
        "suisse",
        "regarding",
        "product",
        "betting",
        "future",
        "swing",
        "p",
        "credit",
        "suisse",
        "tuesday",
        "said",
        "would",
        "terminate",
        "value",
        "plunged",
        "company",
        "statement",
        "roche",
        "holding",
        "ag",
        "purchase",
        "share",
        "tender",
        "offer",
        "ignyta",
        "novartis",
        "ag",
        "say",
        "get",
        "fda",
        "approval",
        "cosentyx",
        "label",
        "update",
        "include",
        "scalp",
        "psoriasis",
        "zur",
        "rose",
        "group",
        "ag",
        "say",
        "draft",
        "coalition",
        "agreement",
        "germany",
        "rx",
        "ban",
        "justified",
        "interest",
        "patient",
        "therefore",
        "take",
        "necessary",
        "legal",
        "operative",
        "step",
        "germany",
        "european",
        "level",
        "molecular",
        "partner",
        "ag",
        "operating",
        "loss",
        "chf",
        "million",
        "net",
        "loss",
        "chf",
        "million",
        "basellandschaftliche",
        "kantonalbank",
        "fy",
        "profit",
        "million",
        "franc",
        "level",
        "previous",
        "year",
        "leonteq",
        "ag",
        "net",
        "profit",
        "improved",
        "chf",
        "million",
        "leclanche",
        "sa",
        "say",
        "building",
        "complete",
        "energy",
        "storage",
        "system",
        "commercial",
        "industrial",
        "application",
        "nrstor",
        "c",
        "canada",
        "bank",
        "cler",
        "ag",
        "annual",
        "profit",
        "chf",
        "million",
        "chf",
        "million",
        "emmi",
        "ag",
        "sale",
        "chf",
        "million",
        "increase",
        "glarner",
        "kantonalbank",
        "operating",
        "income",
        "increase",
        "million",
        "franc",
        "net",
        "income",
        "increase",
        "per",
        "cent",
        "million",
        "franc",
        "vifor",
        "pharma",
        "ag",
        "ferroportin",
        "inhibitor",
        "enters",
        "clinical",
        "trial",
        "lem",
        "holding",
        "sa",
        "9mth",
        "booking",
        "amounted",
        "chf",
        "million",
        "increase",
        "chf",
        "million",
        "economy",
        "reporting",
        "zurich",
        "newsroom"
    ]
}